Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

NCT02423915 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: Rituximab
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Radiation
PROCEDURE: Fucosylated Regulatory T Cells
PROCEDURE: Cord Blood Infusions
DRUG: Mycophenolate mofetil
DRUG: Sirolimus
PROCEDURE: Bone Marrow Aspiration
DRUG: G-CSF
PROCEDURE: Non-Fucosylated Regulatory T Cells

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]